NO961204D0 - Triaryletylenderivater for anvendelse innen terapi - Google Patents

Triaryletylenderivater for anvendelse innen terapi

Info

Publication number
NO961204D0
NO961204D0 NO961204A NO961204A NO961204D0 NO 961204 D0 NO961204 D0 NO 961204D0 NO 961204 A NO961204 A NO 961204A NO 961204 A NO961204 A NO 961204A NO 961204 D0 NO961204 D0 NO 961204D0
Authority
NO
Norway
Prior art keywords
therapy
derivatives
agents
triarylethylene
triarylethylene derivatives
Prior art date
Application number
NO961204A
Other languages
English (en)
Other versions
NO961204L (no
NO306292B1 (no
Inventor
Donald Paul Matthews
Alan Joseph Bitonti
William Anthony Van Sickle
Donald Alan Kaplan
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/259,797 external-priority patent/US5525633A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO961204L publication Critical patent/NO961204L/no
Publication of NO961204D0 publication Critical patent/NO961204D0/no
Publication of NO306292B1 publication Critical patent/NO306292B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961204A 1993-09-24 1996-03-25 Triaryletylenderivater for anvendelse innen terapi NO306292B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12661493A 1993-09-24 1993-09-24
US08/259,797 US5525633A (en) 1993-09-24 1994-06-15 Triaryl-ethylene derivatives
PCT/US1994/009314 WO1995008528A1 (en) 1993-09-24 1994-08-19 Triaryl-ethylene derivatives for use in therapy

Publications (3)

Publication Number Publication Date
NO961204L NO961204L (no) 1996-03-25
NO961204D0 true NO961204D0 (no) 1996-03-25
NO306292B1 NO306292B1 (no) 1999-10-18

Family

ID=26824862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961204A NO306292B1 (no) 1993-09-24 1996-03-25 Triaryletylenderivater for anvendelse innen terapi

Country Status (17)

Country Link
US (1) US5684004A (no)
EP (1) EP0720597B1 (no)
JP (1) JPH09503761A (no)
CN (1) CN1131415A (no)
AT (1) ATE165594T1 (no)
AU (1) AU678535B2 (no)
CA (1) CA2171728C (no)
DE (1) DE69409961T2 (no)
DK (1) DK0720597T3 (no)
ES (1) ES2115975T3 (no)
FI (1) FI961339A7 (no)
HU (1) HUT75933A (no)
IL (1) IL111018A0 (no)
NO (1) NO306292B1 (no)
NZ (1) NZ273433A (no)
PL (1) PL177833B1 (no)
WO (1) WO1995008528A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099093A (en) * 1965-09-03 1968-01-17 Ici Ltd Alkene derivatives
EP0002097B1 (en) * 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO961204L (no) 1996-03-25
DE69409961D1 (de) 1998-06-04
NZ273433A (en) 1997-11-24
DK0720597T3 (da) 1998-10-07
HUT75933A (en) 1997-05-28
NO306292B1 (no) 1999-10-18
CN1131415A (zh) 1996-09-18
PL313594A1 (en) 1996-07-08
EP0720597A1 (en) 1996-07-10
FI961339L (fi) 1996-03-22
AU7670794A (en) 1995-04-10
HU9600727D0 (en) 1996-05-28
CA2171728C (en) 2001-11-13
DE69409961T2 (de) 1998-09-10
CA2171728A1 (en) 1995-03-30
ATE165594T1 (de) 1998-05-15
IL111018A0 (en) 1994-11-28
US5684004A (en) 1997-11-04
AU678535B2 (en) 1997-05-29
PL177833B1 (pl) 2000-01-31
EP0720597B1 (en) 1998-04-29
FI961339A0 (fi) 1996-03-22
ES2115975T3 (es) 1998-07-01
WO1995008528A1 (en) 1995-03-30
JPH09503761A (ja) 1997-04-15
FI961339A7 (fi) 1996-03-22

Similar Documents

Publication Publication Date Title
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
PT935465E (pt) Compostos novos de imidazole substituido
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
ID23374A (id) Halogenopirimidin
ATE247470T1 (de) Neue substituierte imidazolverbindungen
DK0711140T3 (da) Antimykotisk opløsning til negle
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
HU9300486D0 (en) Hydroxi-urea derivatives
DK0569505T3 (da) 3-Difluormethylpyrazolcarboxamidfungicider
FI953497A7 (fi) Spirosykloalkyylisubstituoidut atsetidinonit, jotka ovat käyttökelpoisia hypokolesteroleemisina aineina
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
MX9201681A (es) 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas.
RU95101375A (ru) Производные n-(3-аминопропил)-n-фенил-5,6,7,8-тетрагидронафталин-2-карбоксамида, их получение и применение в терапии
NO961204L (no) Triaryletylenderivater for anvendelse innen terapi
BG100248A (bg) Инхибитори на скваленсинтетаза
BG101221A (bg) N-заместени азабициклохептанови производни, приложими като невролептици
ES2152315T3 (es) Xamoneline tartrato.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
TR200103126T2 (tr) Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri
BR9611904A (pt) Dioxidos de ditiazol
ES1020705Y (es) Maquina portatil perfeccionada multiuso.
ES1024223Y (es) Unidad hermetica de uso personal.